TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Astimex Pharma AB
Closing information (x1000 DKK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
48,047
|
33,751
|
27,813 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
21,864
|
12,163
|
7,844 |
| EBITDA |
20,949
|
11,776
|
7,887 |
| Total assets |
34,518
|
41,201
|
36,866 |
| Current assets |
34,440
|
41,029
|
36,722 |
| Current liabilities |
7,242
|
4,960
|
5,368 |
| Equity capital |
25,138
|
34,184
|
29,984 |
| - share capital |
66
|
63
|
70 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
72.8%
|
83.0%
|
81.3% |
| Turnover per employee |
8,008
|
5,625
|
4,636 |
| Profit as a percentage of turnover |
45.5%
|
36.0%
|
28.2% |
| Return on assets (ROA) |
63.3%
|
29.5%
|
21.3% |
| Current ratio |
475.6%
|
827.2%
|
684.1% |
| Return on equity (ROE) |
87.0%
|
35.6%
|
26.2% |
| Change turnover |
12,962
|
8,535
|
1,070 |
| Change turnover % |
37%
|
34%
|
4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.